Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis products.
Related Posts
A ‘tidal wave’ of natural gas supply — the biggest yet — will reshape global markets, says RBC Capital
The expansion is likely to lead to a state of oversupply by the end of 2026, analysts such as RBC’s Anan Dhanani have projected.
Walmart pulls quarterly operating income forecast, citing Trump’s tariffs
Walmart said it wants to maintain the ability to keep prices low, which could affect its profits.
Trump picks former Senator David Perdue to be ambassador to China
U.S. President-elect Donald Trump said on Thursday he has chosen former Senator David Perdue to be ambassador to China.